Media contacts:
Holly Korschun, 404/727-3990,
Kathi Ovnic, 404/727-9371,
Janet Christenbury, 404/727-8599,
April 10, 2002


Emory University Lecture on Pursuit of AIDS Vaccine Celebrates Opening of Hope Clinic

To celebrate the dedication of The Hope Clinic — a newly created Emory clinical research facility devoted to clinical trials of promising new vaccines and therapeutic interventions — the Emory Vaccine Research Center will sponsor a public lecture on "Opportunities and Challenges in the Pursuit of an AIDS Vaccine."

The lecture, by Mark Feinberg, M.D., Ph.D., medical director of The Hope Clinic and Emory professor of medicine and microbiology and immunology, will take place Wednesday, April 24 at 7 p.m. in the Woodruff Health Sciences Center Administration Building Auditorium at 1440 Clifton Rd. on the Emory campus. The lecture is free and open to the public.

Dr. Feinberg will discuss some of the most exciting work of our times. In the 20 years since AIDS was first identified, HIV infection has emerged as the most devastating disease humankind has ever faced. Dr. Feinberg will talk about the critical need for an effective AIDS vaccine, the challenges to its successful development, and explain how recent research advances at Emory and elsewhere are providing hopeful opportunities to enable achievement of this essential goal.

The lecture is also a thank you to the community, says Dr. Feinberg, especially those generous Atlantans who participate in clinical trials of promising new vaccines out of respect for science and love of humanity. The Emory Vaccine Research Center is home to one of the largest basic and preclinical vaccine research programs at any university worldwide.

The Hope Clinic of the Emory Vaccine Research Center provides new opportunities to translate basic research findings into useful clinical advances to ameliorate global public health threats, including AIDS and malaria. The clinic is strategically located in downtown Decatur to enable community-based clinical research. It was created through the combined efforts of the Emory University School of Medicine, the Yerkes Regional Primate Research Center and the Emory Center for AIDS Research (CFAR).

Dr. Feinberg has been a national leader in HIV research since the earliest days of the epidemic. Prior to joining the Emory faculty in 1998, he served as medical officer for the Office of AIDS Research at the National Institutes of Health (NIH) and as chair of the NIH Coordinating Committee on AIDS Etiology and Pathogenesis Research. He has held numerous national leadership positions in AIDS and HIV research. He has been a member of scientific review panels for the NIH, the World AIDS Foundation and the Pediatric AIDS Foundation. He served as the executive secretary of the NIH Panel to Define Principles of Therapy of HIV Infection that issued recommendations concerning the optimal use of newly available antiretroviral drugs.

After receiving both his M.D. and his Ph.D. from Stanford University School of Medicine, Dr. Feinberg completed his residency at Harvard's Brigham and Women's Hospital. He conducted research in the laboratory of Dr. David Baltimore at the Whitehead Institute for Biomedical Research in Cambridge, Mass. Dr. Feinberg was on the faculty of the University of California at San Francisco (UCSF) from 1991-1995 and was associate director of the UCSF Center for AIDS Research and director of the UCSF CFAR Virology Core Laboratory. He has served on the Committee for Oversight of AIDS Activities at the Institute of Medicine and the National Academy for Sciences and on the Institute of Medicine's Roundtable for the Development of AIDS Drugs and Vaccines. In 1997 Dr. Feinberg received the five-year Elizabeth Glaser Scientist Award from the Pediatric AIDS Foundation to support his research in HIV vaccine development.

He is principal investigator of several HIV/AIDS biomedical prevention (vaccines, microbicides) and sociocultural studies (human decision making related to HIV vaccines) that are relevant to women's health. At The Hope Clinic of the Emory Vaccine Research Center, Dr. Feinberg has been conducting Phase I clinical trials to assess the safety and immunogenicity of several experimental AIDS vaccines. In the laboratory, he is developing additional vaccine strategies and studying the specific mechanisms of immune response to vaccines.

For more information about Dr. Feinberg's Emory lecture, please call 404-712-9266.

Return to April Index

For more general information on The Robert W. Woodruff Health Sciences Center
call Health Sciences Communication's Office at 404-727-5686,
or send e-mail to

Copyright © Emory University, 2001. All Rights Reserved.